ID: ALA2289660

Max Phase: Preclinical

Molecular Formula: C9H11N

Molecular Weight: 133.19

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC=C(C)c1cccnc1

Standard InChI:  InChI=1S/C9H11N/c1-3-8(2)9-5-4-6-10-7-9/h3-7H,1-2H3

Standard InChI Key:  SFBZRYNUSRYNQU-UHFFFAOYSA-N

Associated Targets(non-human)

Bombyx mori 577 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 133.19Molecular Weight (Monoisotopic): 133.0891AlogP: 2.50#Rotatable Bonds: 1
Polar Surface Area: 12.89Molecular Species: NEUTRALHBA: 1HBD: 0
#RO5 Violations: 0HBA (Lipinski): 1HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 4.85CX LogP: 2.18CX LogD: 2.18
Aromatic Rings: 1Heavy Atoms: 10QED Weighted: 0.57Np Likeness Score: 0.11

References

1. YOSHIDA T, SHIOTSUKI T, KUWANO E.  (2000)  Synthesis and Precocious Metamorphosis-Inducing Activity of 3-(1-Alkenyl) pyridines,  25  (3): [10.1584/jpestics.25.253]

Source